FULLER & THALER ASSET MANAGEMENT, INC. - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 211 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 3.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
FULLER & THALER ASSET MANAGEMENT, INC. ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$3,000
-62.5%
111
-62.1%
0.00%
Q3 2021$8,000
-100.0%
293
-99.9%
0.00%
-100.0%
Q2 2021$16,080,000
+92.7%
522,260
+63.9%
0.10%
+76.3%
Q1 2021$8,344,000
-74.5%
318,706
-75.5%
0.06%
-80.5%
Q4 2020$32,759,000
+59.8%
1,302,015
+32.4%
0.30%
+17.0%
Q3 2020$20,494,000
-9.8%
983,395
+2.8%
0.26%
-13.1%
Q2 2020$22,727,000
+152.0%
956,924
+90.9%
0.30%
+96.1%
Q1 2020$9,020,000
-26.8%
501,392
-3.4%
0.15%
+10.9%
Q4 2019$12,317,000
-46.1%
519,271
-37.6%
0.14%
-49.4%
Q3 2019$22,870,000
+329.2%
832,247
+416.7%
0.27%
+337.1%
Q2 2019$5,329,000
+177533.3%
161,057
+101834.8%
0.06%
Q2 2015$3,0001580.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders